Get the Stockscreener App
0.7411
0.96%
0.0011
Harvard Bioscience Inc stock is traded at $0.7411, with a volume of 320.48K.
It is up +0.96% in the last 24 hours and up +83.16% over the past month.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.
See More
Previous Close:
$0.74
Open:
$0.7519
24h Volume:
320.48K
Relative Volume:
0.05
Market Cap:
$33.22M
Revenue:
$106.79M
Net Income/Loss:
$-8.73M
P/E Ratio:
-3.7055
EPS:
-0.2
Net Cash Flow:
$10.81M
1W Performance:
+20.56%
1M Performance:
+83.16%
6M Performance:
+122.22%
1Y Performance:
-65.89%
1-Day Range:
$0.7118
$0.77
1-Week Range:
$0.5617
$0.77
52-Week Range:
$0.2813
$2.38
Harvard Bioscience Inc Stock (HBIO) Company Profile
Name
Harvard Bioscience Inc
Sector
Industry
Phone
(508) 893-8999
Address
84 OCTOBER HILL RD, HOLLISTON, MA
Compare HBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HBIO
Harvard Bioscience Inc
|
0.7452 | 32.99M | 106.79M | -8.73M | 10.81M | -0.20 |
|
ISRG
Intuitive Surgical Inc
|
576.25 | 205.21B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
195.13 | 56.03B | 21.84B | 1.68B | 2.67B | 5.8322 |
|
ALC
Alcon Inc
|
79.60 | 39.13B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
255.92 | 37.34B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
275.76 | 20.20B | 2.96B | 487.70M | 344.00M | 6.6758 |
Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-09-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Mar-10-23 | Upgrade | The Benchmark Company | Speculative Buy → Buy |
| Jan-07-21 | Upgrade | The Benchmark Company | Speculative Buy → Buy |
| Dec-09-20 | Initiated | Northland Capital | Outperform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Jul-08-19 | Downgrade | Janney | Buy → Neutral |
| Jan-24-18 | Reiterated | Janney | Buy |
| Jan-23-18 | Reiterated | The Benchmark Company | Buy |
| Nov-17-16 | Initiated | Singular Research | Buy |
| Jul-28-15 | Initiated | The Benchmark Company | Buy |
View All
Harvard Bioscience Inc Stock (HBIO) Latest News
Is Harvard Bioscience Inc. (HBI) stock worth buying before Fed actionQuarterly Profit Report & Weekly High Conviction Ideas - newser.com
Key resistance and support levels for Harvard Bioscience Inc.Quarterly Profit Report & Weekly Market Pulse Updates - newser.com
How Harvard Bioscience Inc. (HBI) stock compares with tech leadersPortfolio Value Summary & Weekly Stock Breakout Alerts - newser.com
Can Harvard Bioscience Inc. (HBI) stock stage a strong rebound this quarterEarnings Beat & Stepwise Trade Signal Implementation - newser.com
Is Harvard Bioscience Inc. (HBI) stock cheap vs fundamentalsShort Setup & Advanced Technical Analysis Signals - newser.com
Will Harvard Bioscience Inc. (HBI) stock benefit from mergers2025 Buyback Activity & Expert Approved Trade Ideas - newser.com
Will Harvard Bioscience Inc. stock gain from strong economyWeekly Risk Summary & Daily Technical Forecast Reports - newser.com
How Harvard Bioscience Inc. stock trades before earningsJuly 2025 Technicals & Stepwise Entry/Exit Trade Alerts - newser.com
Using fundamentals and technicals on Harvard Bioscience Inc.July 2025 Levels & Reliable Breakout Forecasts - newser.com
Analyzing Harvard Bioscience Inc. with risk reward ratio chartsJuly 2025 Earnings & Daily Stock Trend Reports - newser.com
Wall Street Zen Upgrades Harvard Bioscience (NASDAQ:HBIO) to “Buy” - Defense World
Harvard Bioscience (NASDAQ:HBIO) Upgraded to Buy at Wall Street Zen - Defense World
Why Harvard Bioscience Inc. stock is seen as undervalued2025 Support & Resistance & Weekly Momentum Stock Picks - newser.com
What moving averages say about Harvard Bioscience Inc.July 2025 Big Picture & Safe Entry Momentum Stock Tips - newser.com
What drives Harvard Bioscience Inc stock priceMerger & Acquisition Updates & Free High Yield Portfolio Picks - earlytimes.in
Can Harvard Bioscience Inc. stock hit analyst price targets2025 Investor Takeaways & Daily Price Action Insights - newser.com
Is Harvard Bioscience Inc. stock a contrarian buy2025 Pullback Review & Long Hold Capital Preservation Tips - newser.com
Is Harvard Bioscience Inc. stock a buy before product launchesJuly 2025 Gainers & Long-Term Safe Investment Ideas - newser.com
Will Harvard Bioscience Inc. stock benefit from sector rotationJuly 2025 Opening Moves & Verified Chart Pattern Signals - newser.com
Harvard Bioscience Inc Stock (HBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.39%
0.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):